CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
- Status
- COMPLETED
- Phase
- N/A
Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia
- Status
- COMPLETED
- Phase
- PHASE2
Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
- Status
- COMPLETED
- Phase
- N/A
The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial
- Status
- COMPLETED
- Phase
- NA
T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
- Status
- UNKNOWN
- Phase
- N/A
Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell Lymphomas
- Status
- WITHDRAWN
- Phase
- PHASE1
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Status
- COMPLETED
- Phase
- PHASE2
TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE4
ADYNOVATE Drug Use-Results Survey
- Status
- COMPLETED
- Phase
- N/A
NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"
- Status
- COMPLETED
- Phase
- N/A
Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response
- Status
- TERMINATED
- Phase
- NA